BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3040% above fair value
$72.80−0.04 (-0.05%)
Close on Nov 13, 2026Market cap $11.43BP/E 66.8Yield 0.44%
Bio-Techne net income
Net income is the profit left for shareholders after every expense, interest and tax.
Bio-Techne's net income for the twelve months ending Mar 31, 2026 was $109.56M, down 16.8% year over year. For fiscal 2025 it was $73.40M, down 56.3% from the year before. Over ten years it grew -3.8% a year on average. The highest annual figure on record is $285.26M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $73.40M | -56.3% |
| FY2024 | Jun 30, 2024 | $168.11M | -41.1% |
| FY2023 | Jun 30, 2023 | $285.26M | +4.9% |
| FY2022 | Jun 30, 2022 | $272.05M | +93.8% |
| FY2021 | Jun 30, 2021 | $140.41M | -38.8% |
| FY2020 | Jun 30, 2020 | $229.30M | +138.7% |
| FY2019 | Jun 30, 2019 | $96.07M | -23.8% |
| FY2018 | Jun 30, 2018 | $126.15M | +65.8% |
| FY2017 | Jun 30, 2017 | $76.09M | -27.2% |
| FY2016 | Jun 30, 2016 | $104.48M | -3.0% |
| FY2015 | Jun 30, 2015 | $107.74M | -2.9% |
| FY2014 | Jun 30, 2014 | $110.95M | -1.4% |
| FY2013 | Jun 30, 2013 | $112.56M | +0.2% |
| FY2012 | Jun 30, 2012 | $112.33M | +0.0% |
| FY2011 | Jun 30, 2011 | $112.30M | +2.3% |
| FY2010 | Jun 30, 2010 | $109.78M | +4.3% |
| FY2009 | Jun 30, 2009 | $105.24M | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $28.29M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $51.05M | +126.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $38.01M | +8.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $38.19M | +13.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$17.68M | -143.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $22.59M | -54.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $34.89M | +27.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $33.60M | -34.1% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $40.59M | -46.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $49.06M | -30.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $27.47M | -45.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $50.99M | -43.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $75.48M | +22.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $70.22M | +15.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $50.01M | -37.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $89.56M | +28.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $61.52M | +311.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $60.74M | +32.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $80.17M | +73.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $69.62M | +108.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $14.96M | -74.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $45.78M | +25.7% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $46.27M | -61.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $33.40M | +131.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $58.85M | +257.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $36.43M | -18.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $119.62M | +581.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $14.40M | -17.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $16.46M | -60.5% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $44.65M | +126.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $17.56M | -64.1% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $17.40M | +9.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $41.70M | +51.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $19.74M | -11.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $48.85M | +554.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $15.86M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $27.61M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $22.17M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $7.47M | – |
See a number that looks wrong?